Who owns BRAINSTORM CELL THERAPEUTICS?

Tip: Access positions for across all investors

Analyze quarterly positions in Brainstorm Cell Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Brainstorm Cell Therapeutics stock

Who bought or sold BRAINSTORM CELL THERAPEUTICS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Morgan Stanley 5.8k $6.5k 100% Jun 2025
 View chart
Advisor Group Holdings 1.8k $1.4k 0% Sep 2025
 View chart
Bangor Savings Bank 266.00 $188.008800 0% Sep 2025
 View chart
VSM Wealth Advisory 120.00 $84.996000 0% Sep 2025
 View chart
Steward Partners Investment Advisory 113.00 $80.004000 0% Sep 2025
 View chart
D. J. St. Germain 33.00 $23.001000 0% Sep 2025
 View chart

Who sold out of Brainstorm Cell Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Caldwell Sutter Capital Jun 2025 157k $0
Geode Capital Management Jun 2025 55k $61k
Vanguard Group Jun 2025 28k $31k
Gunderson Capital Management Jun 2025 26k $29k
BlackRock Jun 2025 25k $28k
Liberty Wealth Management Jun 2025 23k $25k
Weaver Consulting Group Jun 2025 16k $18k
UBS Group Jun 2025 12k $14k
Traynor Capital Management Jun 2025 11k $12k
LPL Financial Jun 2025 11k $12k
Almanack Investment Partners Jun 2025 10k $11k
Raymond James Financial Jun 2025 5.2k $5.8k
Harbour Investments Jun 2025 3.6k $4.0k
Wells Fargo & Company Jun 2025 1.3k $1.5k
Activest Wealth Management Jun 2025 334.00 $374.013200
SBI Securities Jun 2025 218.00 $244.007400
Jones Financial Companies, L.L Jun 2025 216.00 $229.003200
Jpmorgan Chase & Co Mar 2025 171.00 $205.200000
Hartland & Co Jun 2025 100.00 $112.000000
Cranbrook Wealth Management Jun 2025 66.00 $73.999200